Career opportunities


Chief Business Officer

· Full-time

About The Position

About the position

Imagene is looking to hire a Chief Business Officer based in the US, responsible for initiating and leading commercial collaborations with pharmaceutical companies, medical institutions, and laboratories within the genomic sequencing and cancer care landscape.

We’re looking for a strong, experienced, and success-driven leader with a proven track record of closing biopharma business deals. The desired candidate should have a deep understanding of the oncology and US healthcare space, strong relationships and substantial network of contacts in biopharma companies, ability to shape the business strategy, map customer needs, and negotiate complex contracts.


What You'll Be Doing

  • Serve as a member of the executive leadership team, collaborate with the CEO in setting the business strategy and vision
  • Overall responsibility for identifying, evaluating, negotiating, securing, and managing business opportunities - “hands-on” execution of the company strategy
  • Lead and recruit the business team
  • Build and maintain relationships with biopharma companies and other providers (medical centers and private labs).
  • Responsible for identifying new business opportunities
  • Identify, evaluate, and build the strategic justification for new products/markets


  • 8+ years in business development/sales experience, primarily in the biopharmaceutical industry
  • Experience with the US market
  • Existing relationships within the pharma/biotech/medical centers space
  • Experience in working with large and complex customers, including gaining access to key executives and stakeholders and successfully managing relationships
  • Excellent communication skills in English, both verbal and written
  • Advanced degree (PhD, MD, or MBA)
  • Deep knowledge of the precision oncology landscape – An advantage

Apply for this position

About Imagene

Imagene develops an AI platform for biomarkers identification and response prediction that delivers real-time molecular analysis using only a digitized biopsy image.

We drive a new approach for treatment response prediction that encapsulates the uniqueness of each patient, bringing cancer care closer to reaching the full potential of precision medicine.

Imagene's technology classifies patterns that cannot be seen by the human eye, evolving genomics, proteomics, and spatial insights to understand better the recurrence of specific cancers and their resistance mechanisms; this enables better stratification of patients in clinical trials and the discovery of novel targets for new drugs. Imagene collaborates with top-tier medical centers and pharmaceutical companies worldwide to improve the overall quality of care and accelerate the drug development process.

Our success derives from our cutting-edge technology and talented multidisciplinary team of data scientists, biologists, software engineers, and medical experts.